Broadcom Inc (AVGO) Q1 2025 Earnings Call Highlights: Record Revenue and AI Growth Propel ...
Total Revenue: $19 billion, up 25% year on year.
Adjusted EBITDA: $10.1 billion, up 41% year on year.
Semiconductor Revenue: $8.2 billion, up 11% year on year.
AI Revenue: $4.1 billion, up 77% year on year.
Infrastructure Software Revenue: $6.7 billion, up 47% year on year.
Gross Margin: 79.1% of revenue.
Operating Income: $9.8 billion, up 44% year on year.
Operating Margin: 66% of revenue.
Free Cash Flow: $6 billion, representing 40% of revenue.
Capital Expenditures: $100 million.
Cash and Debt: $9.3 billion in cash and $68.8 billion in gross principal debt.
Dividends Paid: $2.8 billion in cash dividends.
Share Repurchase: $2 billion to repurchase 8.7 million shares.
Q2 Revenue Guidance: $14.9 billion, up 19% year on year.
Q2 AI Revenue Guidance: $4.4 billion, up 44% year on year.
Q2 Infrastructure Software Revenue Guidance: $6.5 billion, up 23% year on year.
Warning! GuruFocus has detected 6 Warning Signs with DOMO.
Release Date: March 06, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Broadcom Inc (NASDAQ:AVGO) reported a record total revenue of $19 billion for fiscal Q1 2025, up 25% year on year.
AI revenue reached $4.1 billion, up 77% year on year, surpassing the guidance of $3.8 billion.
The company is making significant R&D investments in AI, including the development of the industry's first 2-nanometer AI XPU.
Infrastructure software revenue grew by 47% year on year, driven by the integration of VMware and the shift to subscription-based models.
Broadcom Inc (NASDAQ:AVGO) is expanding its customer base, with four additional hyperscalers engaged in developing custom AI accelerators.
Non-AI semiconductor revenue was down 9% sequentially due to a seasonal decline in wireless.
Enterprise networking remains flat as customers work through channel inventory.
Industrial sales were down double digits in Q1 and are expected to decline further in Q2.
Free cash flow as a percentage of revenue is impacted by cash interest expenses and cash taxes.
Concerns about geopolitical tensions and potential regulatory impacts on AI diffusion rules could pose risks to future operations.
Q: Hock, you talked about four more customers coming online. Can you elaborate on the trend you're seeing? Can any of these customers be as significant as the current three? A: Hock Tan, President and CEO: These four are not yet customers as we define it. We enable hyperscalers to create compute systems, and it takes time to develop the software to make it work. There's no reason these four won't create demand similar to the first three, but it will likely happen later.
Q: Can you provide more color on the second-half AI profile, especially with the new 3-nanometer AI accelerator programs ramping? A: Hock Tan, President and CEO: We are seeing improved networking shipments and some pull-ins of shipments. However, I won't speculate on the second half beyond what we've guided.
Q: Are you seeing disruptions from tariffs or other dynamics, and how might this impact Broadcom's growth? A: Hock Tan, President and CEO: It's too early to tell about tariffs, but generative AI is accelerating semiconductor technology development. We're seeing innovation in higher performance accelerators and networking functionality.
Q: How do you view the conversion from design wins to deployment, especially with the new XPU engagements? A: Hock Tan, President and CEO: We define design wins as products produced at scale and deployed in production. It takes time from taping out to scale production, and we focus on partners who need large volumes.
Q: Is there any concern about new regulations impacting your AI design wins or shipments? A: Hock Tan, President and CEO: In this era of geopolitical tensions, there's always some concern, but we don't have any specific concerns about our current customers.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Nvidia Stock Jumps as Jefferies Sees Margins 'Could Skyrocket to 80%'
June 3 - Shares of Nvidia (NASDAQ:NVDA) climbed about 3% Tuesday morning after Jefferies named the chipmaker a top stock pick and projected profit margins could hit as high as 80% this year. Warning! GuruFocus has detected 4 Warning Signs with NVDA. Jefferies analyst Blayne Curtis added Nvidia to the firm's highest conviction list, citing the ramp-up of next-generation Blackwell chips. In his view, mounting demand for Blackwell is poised to drive a significant margin expansion. Currently, Nvidia's gross margins sit near 61%, but Jefferies predicts they could leap toward 80% as Blackwell volumes accelerate. Margins at that level are rare in hardware, underscoring Nvidia's robust pricing power and market position. The firm says Nvidia has evolved beyond selling standalone chips, emerging as a comprehensive AI infrastructure provider. Customers ranging from hyperscale datacenters to hedge funds are lining up for its combined hardware, software, and systems offerings. Continuous software licensing and large-scale deployments are expected to bolster profitability as AI workloads proliferate. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22 minutes ago
- Yahoo
The $17 Trillion Illusion? Why One Wall Street Legend Says Alternatives Are a Costly Scam
Wall Street may be calling this the golden age of alternative investments but Richard Ennis sees something very different. The retired investment consultant and former Financial Analysts Journal editor just published a scathing new study arguing that hedge funds, private equity, and other alt strategies aren't pulling their weight. In fact, he claims they're quietly draining performance from the very portfolios they're meant to boost. Endowments holding 65% in alternatives underperformed a simple stock-bond benchmark by 2.4% annually over 16 years through June 2024. Pensions, with 35% exposure, trailed by 1%. That shortfall, Ennis points out, suspiciously mirrors the average costs of these vehicles. Warning! GuruFocus has detected 8 Warning Signs with KKR. His core argument? The complexity of alternatives masks an inconvenient truth: high fees and ordinary returns. Ennis believes the entire system runs more on narrative than numbers and consultants, CIOs, and multi-strategy funds are incentivized to keep the machine humming. Alts bring extraordinary costs but ordinary returns, he writes in The Demise of Alternative Investments, soon to be published in the Journal of Portfolio Management. Despite the underperformance, the asset class continues to balloon. According to Preqin, the alt industry held $17 trillion in assets by end-2023 and could hit $29 trillion by 2029. Firms like KKR (NYSE:KKR), and others now repackaging these vehicles into semi-liquid funds for retail investors, call it a golden age. Ennis calls it something else entirely: a slow-moving cost trap. Some argue Ennis is cherry-picking the timeline starting in 2009, when stocks ran hot and nearly everything else lagged behind. Others defend alts for reasons beyond return: reducing volatility, hedging inflation, and improving long-term outcomes. But Ennis remains unmoved. To him, passive indexing not private equity or hedge funds offers the most consistent value. And while public market names like Tesla (TSLA) continue to dominate the performance charts, the real story could be that institutions chasing sophistication are paying steep premiums for subpar results. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Wegovy Use Among U.S. Teens Jumps 50% in 2024: Truveta
Novo Nordisk (NVO, Financials) is seeing more U.S. teens start treatment with its GLP-1 drug Wegovy; new data shows a 50% increase in prescriptions in 2024. According to health tech firm Truveta, the average rate climbed to 14.8 per 100,000 adolescents; that's up from 9.9 in 2023the first full year Wegovy was available for kids aged 12 and older. Warning! GuruFocus has detected 6 Warning Signs with BA. The data, drawn from 1.3 million patients across 30 health systems, points to growing comfort among doctors and families. Still, use remains limited; roughly 8 million U.S. teens live with obesity, but only a fraction are getting this class of medication. At Nemours Children's Hospital in Delaware, about 25% of patients in its obesity program were prescribed a GLP-1 in 2024; that figure nearly doubled from the year prior. On average, those teens lost 15 pounds (6.8 kg) within six to 12 months; some lost more with longer use. Access, however, remains uneven. Many families face insurance rejections; others worry about safety over the long run. U.S. Health Secretary Robert F. Kennedy Jr. has criticized widespread pediatric use of these drugs; his report cited concerns over metabolism and development. Novo Nordisk said its clinical trials showed no impact on teen growth or puberty; Eli Lilly (LLY, Financials), which is running late-stage trials for its Zepbound drug in adolescents, echoed that viewstating no signs of growth or metabolic harm so far. Why it matters: The teen uptick signals rising demand for long-term obesity care; however, pushback from regulators, slow insurance uptake, and the need for more data could stall momentum. This article first appeared on GuruFocus.
